Cantor Fitzgerald Starts Centene (CNC) at Buy; Among the Best Positioned

Cantor Fitzgerald initiates coverage on Centene (NYSE: CNC) with a Buy. PT $47.50.

Cantor analyst says, "Centene is among the best positioned Medicaid managed care companies in terms of its ability to capitalize on the growing role of managed care in state Medicaid programs. The company added substantial new business in 2011 that will help 2012, and there will be a steady stream of new catalysts over the next three years as more states issue RFPs. Many of these states are markets where Centene already has operations. New business will boost next year's revenue by nearly $2 billion."

For an analyst ratings summary and ratings history on Centene click here. For more ratings news on Centene click here.

Shares of Centene closed at $38.44 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Argus Upgrades Centene (CNC) to Buy
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
• MHS Serves Announces Recipients of over $2 Million Investment in Hoosier Employment